Bausch + Lomb Corp
NYSE:BLCO
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Bausch + Lomb Corp
Cash & Cash Equivalents
Bausch + Lomb Corp
Cash & Cash Equivalents Peer Comparison
OTC
COO
Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors
| Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
B
|
Bausch + Lomb Corp
NYSE:BLCO
|
Cash & Cash Equivalents
$331m
|
CAGR 3-Years
12%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Ocumetics Technology Corp
XTSX:OTC
|
Cash & Cash Equivalents
CA$235.8k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Z
|
Zentek Ltd
XTSX:ZEN
|
Cash & Cash Equivalents
CA$5.3m
|
CAGR 3-Years
36%
|
CAGR 5-Years
14%
|
CAGR 10-Years
8%
|
|
|
Ostrom Climate Solutions Inc
XTSX:COO
|
Cash & Cash Equivalents
CA$745.2k
|
CAGR 3-Years
20%
|
CAGR 5-Years
13%
|
CAGR 10-Years
10%
|
See Also
What is Bausch + Lomb Corp's Cash & Cash Equivalents?
Cash & Cash Equivalents
331m
USD
Based on the financial report for Dec 31, 2023, Bausch + Lomb Corp's Cash & Cash Equivalents amounts to 331m USD.
What is Bausch + Lomb Corp's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 3Y
12%
Over the last year, the Cash & Cash Equivalents growth was -6%. The average annual Cash & Cash Equivalents growth rates for Bausch + Lomb Corp have been 12% over the past three years .
You don't have any saved screeners yet
